Cronos Group Inc
CRON: XTSE (CAN)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
CAD 1.20 | Vqvrf | Yqqzjgg |
Cronos Sees Benefits From Strategy, but Its Relative Small Size Remains a Concern
Business Strategy and Outlook
Cronos Group cultivates and sells cannabis predominantly in Canada and hemp-derived CBD in the U.S. but also participates in the global medical cannabis market.